207 related articles for article (PubMed ID: 19503099)
1. Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array.
Radpour R; Kohler C; Haghighi MM; Fan AX; Holzgreve W; Zhong XY
Oncogene; 2009 Aug; 28(33):2969-78. PubMed ID: 19503099
[TBL] [Abstract][Full Text] [Related]
2. High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip.
Radpour R; Haghighi MM; Fan AX; Torbati PM; Hahn S; Holzgreve W; Zhong XY
Mol Cancer Res; 2008 Nov; 6(11):1702-9. PubMed ID: 19010818
[TBL] [Abstract][Full Text] [Related]
3. MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma.
Bellido ML; Radpour R; Lapaire O; De Bie I; Hösli I; Bitzer J; Hmadcha A; Zhong XY; Holzgreve W
Biol Reprod; 2010 Apr; 82(4):745-50. PubMed ID: 20075396
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation in histologically distinct classes of breast cancer.
Bae YK; Brown A; Garrett E; Bornman D; Fackler MJ; Sukumar S; Herman JG; Gabrielson E
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5998-6005. PubMed ID: 15447983
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
[TBL] [Abstract][Full Text] [Related]
6. [Novel methylation and expression markers associated with breast cancer].
Kuznetsova EB; Kekeeva TV; Larin SS; Zemliakova VV; Babenko OV; Nemtsova MV; Zaletaev DV; Strel'nikov VV
Mol Biol (Mosk); 2007; 41(4):624-33. PubMed ID: 17936981
[TBL] [Abstract][Full Text] [Related]
7. Methylation signature of lymph node metastases in breast cancer patients.
Barekati Z; Radpour R; Lu Q; Bitzer J; Zheng H; Toniolo P; Lenner P; Zhong XY
BMC Cancer; 2012 Jun; 12():244. PubMed ID: 22695536
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric analysis of cytosine methylation by base-specific cleavage and primer extension methods.
van den Boom D; Ehrich M
Methods Mol Biol; 2009; 507():207-27. PubMed ID: 18987817
[TBL] [Abstract][Full Text] [Related]
9. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.
Ehrich M; Nelson MR; Stanssens P; Zabeau M; Liloglou T; Xinarianos G; Cantor CR; Field JK; van den Boom D
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15785-90. PubMed ID: 16243968
[TBL] [Abstract][Full Text] [Related]
10. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients.
Van der Auwera I; Bovie C; Svensson C; Trinh XB; Limame R; van Dam P; van Laere SJ; van Marck EA; Dirix LY; Vermeulen PB
BMC Cancer; 2010 Mar; 10():97. PubMed ID: 20226036
[TBL] [Abstract][Full Text] [Related]
11. Differential methylation hybridization profiling identifies involvement of STAT1-mediated pathways in breast cancer.
Kim JH; Kang HS; Kim TW; Kim SJ
Int J Oncol; 2011 Oct; 39(4):955-63. PubMed ID: 21674123
[TBL] [Abstract][Full Text] [Related]
12. MALDI-TOF MS and TaqMan assisted SNP genotyping of DNA isolated from formalin-fixed and paraffin-embedded tissues (FFPET).
Jaremko M; Justenhoven C; Abraham BK; Schroth W; Fritz P; Brod S; Vollmert C; Illig T; Brauch H
Hum Mutat; 2005 Mar; 25(3):232-8. PubMed ID: 15706592
[TBL] [Abstract][Full Text] [Related]
13. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
14. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
15. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
Jeronimo C; Monteiro P; Henrique R; Dinis-Ribeiro M; Costa I; Costa VL; Filipe L; Carvalho AL; Hoque MO; Pais I; Leal C; Teixeira MR; Sidransky D
Breast Cancer Res Treat; 2008 May; 109(1):27-34. PubMed ID: 17549626
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.
Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C
FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747
[TBL] [Abstract][Full Text] [Related]
18. Studies on the methylation status of CpG sequences located in promoters of selected tumour suppressor genes in breast cancer cells.
Fabianowska-Majewska K; Kordek R; Krawczyk B
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1025-8. PubMed ID: 17065058
[TBL] [Abstract][Full Text] [Related]
19. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
20. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
